These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 1331236)

  • 21. Delay in expression of a mammary tumor provirus is responsible for defective clonal deletion during postnatal period.
    Niimi N; Wajjwalku W; Ando Y; Tomida S; Takeuchi M; Ueda M; Kaneda T; Yoshikai Y
    Eur J Immunol; 1994 Feb; 24(2):488-91. PubMed ID: 8299700
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Linkage of Mls genes to endogenous mammary tumour viruses of inbred mice.
    Frankel WN; Rudy C; Coffin JM; Huber BT
    Nature; 1991 Feb; 349(6309):526-8. PubMed ID: 1846948
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MHC class II A alpha and E alpha molecules determine the clonal deletion of V beta 6+ T cells. Studies with recombinant and transgenic mice.
    Anderson GD; Banerjee S; David CS
    J Immunol; 1989 Dec; 143(11):3757-61. PubMed ID: 2531186
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Production of minor lymphocyte stimulatory-1a antigen from activated CD4+ or CD8+ T cells.
    Arase-Fukushi N; Arase H; Ogasawara K; Good RA; Onoé K
    J Immunol; 1993 Nov; 151(9):4445-54. PubMed ID: 8104995
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of Mtv-7 sag gene in vivo using a retroviral vector results in selective inactivation of superantigen reactive T cells.
    Kang J; Ido E; Pawling J; Beutner U; Huber BT; Hozumi N
    J Immunol; 1994 Feb; 152(3):1039-46. PubMed ID: 8301116
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The induction of peripheral tolerance by the chronic activation and deletion of CD4+V beta 5+ cells.
    Fink PJ; Fang CA; Turk GL
    J Immunol; 1994 May; 152(9):4270-81. PubMed ID: 7908916
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Junctional diversity prevents negative selection of an antigen-specific T cell repertoire.
    Kilgannon P; Novak Z; Fotedar A; Singh B
    Mol Immunol; 2010 Feb; 47(5):1154-60. PubMed ID: 19954850
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A V beta 4-specific superantigen encoded by a new exogenous mouse mammary tumor virus.
    Maillard I; Erny K; Acha-Orbea H; Diggelmann H
    Eur J Immunol; 1996 May; 26(5):1000-6. PubMed ID: 8647159
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New infectious mammary tumor virus superantigen with V beta-specificity identical to staphylococcal enterotoxin B (SEB).
    Luther S; Shakhov AN; Xenarios I; Haga S; Imai S; Acha-Orbea H
    Eur J Immunol; 1994 Aug; 24(8):1757-64. PubMed ID: 8056034
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An endogenous retrovirus mediating deletion of alpha beta T cells?
    Woodland DL; Happ MP; Gollob KJ; Palmer E
    Nature; 1991 Feb; 349(6309):529-30. PubMed ID: 1846949
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of superantigen recognition by peptides of the variable region of the T cell receptor beta chain.
    MacNeil D; Fraga E; Singh B
    Eur J Immunol; 1992 Apr; 22(4):937-41. PubMed ID: 1532364
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Concomitant infection with exogenous mouse mammary tumor virus encoding I-E-dependent superantigen in I-E-negative mouse strain.
    Ando Y; Wajjwalku W; Niimi N; Hiromatsu K; Morishima T; Yoshikai Y
    J Immunol; 1995 Jun; 154(12):6219-26. PubMed ID: 7759859
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of the Mls-1a superantigen results in an increased frequency of V beta 14+ T cells.
    Liao NS; Raulet DH
    J Immunol; 1992 Aug; 149(4):1151-5. PubMed ID: 1323609
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of the T cell receptor alpha-chain on T cell reactivity and tolerance to Mls-1 in T cell receptor beta-chain transgenic mice.
    Blackman MA; Smith HP; Le P; Woodland DL
    J Immunol; 1993 Jul; 151(2):556-65. PubMed ID: 8335899
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lack of MMTV superantigen presentation in MHC class II-deficient mice.
    Beutner U; McLellan B; Kraus E; Huber BT
    Cell Immunol; 1996 Mar; 168(2):141-7. PubMed ID: 8640859
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Receptors on T cells escaping superantigen-mediated deletion lack special beta-chain junctional region structural characteristics.
    Pullen AM; Bogatzki LY
    J Immunol; 1996 Mar; 156(5):1865-72. PubMed ID: 8596038
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of CD28 costimulation in immune-mediated responses against mouse mammary tumor viruses.
    Palmer LD; Saha B; Hodes RJ; Abe R
    J Immunol; 1996 Mar; 156(6):2112-8. PubMed ID: 8690899
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The J alpha segment contributes to the affinity of V beta 6+ cells for vSAG-7 (Mls-1a) presented by I-A molecules.
    Churaqui E; Oukka M; Tilloy F; Mayadoux E; Bruley-Rosset M; Kosmatopoulos K
    Immunology; 1995 Apr; 84(4):609-18. PubMed ID: 7790035
    [TBL] [Abstract][Full Text] [Related]  

  • 39. T cells bearing Vbeta8 are preferentially infected with exogenous mouse mammary tumor virus.
    Upragarin N; Nishimura H; Wajjwalku W; Ando Y; Nagafuchi S; Watanabe T; Yoshikai Y
    J Immunol; 1997 Sep; 159(5):2189-95. PubMed ID: 9278306
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preferential use of a T cell receptor V beta gene by acetylcholine receptor reactive T cells from myasthenia gravis-susceptible mice.
    Infante AJ; Levcovitz H; Gordon V; Wall KA; Thompson PA; Krolick KA
    J Immunol; 1992 Jun; 148(11):3385-90. PubMed ID: 1375242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.